https://www.selleckchem.com/products/ms-275.html
Using US prices, the more cost-effective treatment was high-dose prednisolone, with an incremental cost-effectiveness ratio (ICER) of $333 per case of spasms resolved, followed by ACTH, with an ICER of $1432200 per case of spasms resolved. These results were robust to multiple sensitivity analyses and different assumptions. Prednisolone at 4-8mg/kg/day was more cost-effective than ACTH under a wide range of assumptions. For infantile spasm resolution 2weeks after treatment initiation, current evidence does not support the preeminence of
Like
Comment
Share
